Three Ways to Support OCRA in ’23 … in 20 Minutes or Less
Many people talk about New Year’s resolutions in the month of January, which is all well and good. But sometimes these long-range goals don’t exactly stick. Why not focus on … Continued
Page
OCRA-Funded Study Reveals Role of L1CAM in Development and Spread of HGSOC
A recent study, funded in part by OCRA, has shed new light on how the most common subtype of ovarian cancer develops and metastasizes, by identifying a key molecule that … Continued
OCRA-Funded Research Sheds Light On Ovarian Cancer Resistance to Immunotherapy
As immunotherapies have seen rising success in treating several other cancers, researchers are hard at work uncovering why immunotherapy for ovarian cancer has, so far, proven ineffective. In a study … Continued
Melica Brodeur, MD, MSc | Meet a Scientist
Dr. Melica Brodeur, of Memorial Sloan Kettering Cancer Center, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Exploiting SMARCA4 Alterations for New Therapeutics in Ovarian Cancer,” … Continued
2022 Breakthroughs in Ovarian Cancer Research and Treatment
“We are truly in the Golden Age, the Renaissance, if you will, of care for people with ovarian cancer. So much is happening.” Dr. Stephanie Blank Though there is still … Continued
The Overview | December 2022
There are many different celebrations involving light during these dark winter days. And certainly, our community is a great source of brightness — from the hope of scientific breakthroughs on … Continued
Amrita Salvi, PhD | Meet a Scientist
Dr. Amrita Salvi, of University of Illinois at Chicago, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Investigating the Mechanism of Action of PHY34 in HGSOC,” … Continued
Zelei Yang, PhD | Meet a Scientist
Dr. Zelei Yang, of Dana Farber Cancer Institute, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Re-engaging the Anti-tumor Immune Response Against Ovarian Cancer,” Dr. Yang … Continued
Gamze Bildik Elcik, PhD | Meet a Scientist
Dr. Gamze Bildik Elcik, postdoctoral fellow in the Department of Experimental Therapeutics at MD Anderson Cancer Center, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “DIRAS3 … Continued
New Research Points to Persistent Racial Disparities in Ovarian Cancer Care
Recent research published in JNCCN–Journal of the National Comprehensive Cancer Network has shown that there are clear disparities when it comes to which ovarian cancer patients are receiving treatment in accordance with … Continued
Erin Wesley, PhD | Meet a Scientist
Dr. Erin Wesley, of University of Minnesota Twin Cities, is a 2022 recipient of OCRA’s Mentored Investigator Grant. With her project, “Impact of Cytomegalovirus and Inflammation on NK Cells in … Continued
Germline vs Somatic Testing; Genomic vs Genetic Testing — What it Means and Why it Matters
NCCN guidelines for the management of ovarian cancer, as well as fallopian and primary peritoneal cancers, specify that patients diagnosed with those diseases should have germline and somatic testing. But … Continued